← Association for Accessible Medicines
FDANonrulemakingFDA-2018-D-1098

Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) Drug Products - Quality Considerations

RIN
—
Last modified
Sep 17, 2021
Comment window
closed 2870d ago
Association for Accessible Medicines filings
1

Activity

Association for Accessible Medicines filed 1 comment on this docket between Jun 20, 2018 and Jun 20, 2018. 0 other organizations filed here. The comment window closed 2870d ago.

What Association for Accessible Medicines filed (1)

Jun 20, 2018· Comment from Association for Accessible Medicines (AAM)· FDA-2018-D-1098-0023

Comments from The Association for Accessible Medicines (AAM) on behalf of our member companies, regarding Docket FDA-2018-D-1098: Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) Products - Quality Considerations.

View on regulations.gov →

Abstract

No abstract recorded.

View on regulations.gov →

Co-filers (0)

See everyone who commented →